Overall Survival with Osimertinib in Resected <i>EGFR</i>-Mutated NSCLC
AstraZeneca
Masahiro Tsuboi; Roy S Herbst; Thomas John; Terufumi Kato; Margarita Majem; Christian Grohé; Jie Wang; Jonathan W Goldman; Shun Lu; Wu-Chou Su; Filippo de Marinis; Frances A Shepherd; Ki Hyeong Lee; Nhieu Thi Le; Arunee Dechaphunkul; Dariusz Kowalski; Lynne Poole; Ana Bolanos; Yuri Rukazenkov; Yi-Long Wu; ADAURA Investigators